VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 30,700 shares of the company’s stock, valued at approximately $426,000.
Several other hedge funds have also modified their holdings of SGRY. Jupiter Topco LLC acquired a new position in Surgery Partners during the 2nd quarter worth approximately $233,220,000. Pentwater Capital Management LP acquired a new stake in Surgery Partners in the second quarter valued at approximately $195,384,000. BlackRock Inc. purchased a new stake in shares of Surgery Partners during the second quarter valued at approximately $104,857,000. Hsbc Holdings PLC purchased a new stake in shares of Surgery Partners during the second quarter valued at approximately $48,912,000. Finally, Bank of America Corp DE acquired a new position in shares of Surgery Partners during the second quarter worth $20,374,000.
Surgery Partners Trading Up 0.1%
NASDAQ SGRY opened at $23.20 on Friday. Surgery Partners, Inc. has a 12 month low of $11.41 and a 12 month high of $23.37. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.95 and a quick ratio of 1.78. The company has a market capitalization of $3.04 billion, a price-to-earnings ratio of -33.14 and a beta of 1.85. The company’s fifty day moving average price is $16.04 and its two-hundred day moving average price is $14.83.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last released its earnings results on Monday, August 10th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.04. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The company had revenue of $848.90 million during the quarter, compared to the consensus estimate of $830.03 million. During the same quarter in the previous year, the firm earned $0.17 EPS. The company’s revenue was up 2.7% on a year-over-year basis. As a group, research analysts predict that Surgery Partners, Inc. will post 0.07 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research firms recently issued reports on SGRY. JPMorgan Chase & Co. lifted their price target on shares of Surgery Partners from $14.00 to $15.00 and gave the stock a “neutral” rating in a research note on Monday, September 14th. TD Cowen cut shares of Surgery Partners from a “strong-buy” rating to a “hold” rating in a research report on Saturday, October 31st. Stonex Financial downgraded Surgery Partners from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 27th. Benchmark reaffirmed a “buy” rating on shares of Surgery Partners in a research report on Tuesday, August 11th. Finally, UBS Group lowered Surgery Partners from a “buy” rating to a “hold” rating and lifted their target price for the stock from $21.00 to $23.50 in a research report on Wednesday, October 28th. Three research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $20.14.
Get Our Latest Analysis on Surgery Partners
Insider Buying and Selling
In other news, Director Teresa DeLuca acquired 10,000 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was purchased at an average cost of $14.35 per share, with a total value of $143,500.00. Following the completion of the acquisition, the director directly owned 66,843 shares in the company, valued at $959,197.05. This represents a 17.59% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Company insiders own 2.00% of the company’s stock.
Surgery Partners Company Profile
Surgery Partners, Inc is a U.S.-based healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals. The company works with physicians, health systems and other healthcare providers to deliver outpatient surgical care in facilities designed for same-day procedures.
Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.
Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.
Read More
- Five stocks we like better than Surgery Partners
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.
